one-way analysis of variance (anova) followed by bonferroni post hoc test (graphpad prism 8) (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
one-way analysis of variance (anova) followed by bonferroni post hoc test (graphpad prism 8)
One Way Analysis Of Variance (Anova) Followed By Bonferroni Post Hoc Test (Graphpad Prism 8), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/one-way+analysis+of+variance+(anova)+followed+by+bonferroni+post+hoc+test+(graphpad+prism+8)/one+way+analysis+of+variance++anova+/pmc11564992-155-11-19
Average 90 stars, based on 1 article reviews
One Way Analysis Of Variance (Anova) Followed By Bonferroni Post Hoc Test (Graphpad Prism 8), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/one-way+analysis+of+variance+(anova)+followed+by+bonferroni+post+hoc+test+(graphpad+prism+8)/one+way+analysis+of+variance++anova+/pmc11564992-155-11-19
Average 90 stars, based on 1 article reviews
one-way analysis of variance (anova) followed by bonferroni post hoc test (graphpad prism 8) - by Bioz Stars,
2026-10
90/100 stars
Images
1) Product Images from "High-fat and high-carbohydrate diets worsen the mouse brain susceptibility to damage produced by enterohemorrhagic Escherichia coli Shiga toxin 2"
Article Title: High-fat and high-carbohydrate diets worsen the mouse brain susceptibility to damage produced by enterohemorrhagic Escherichia coli Shiga toxin 2
Journal: Heliyon
doi: 10.1016/j.heliyon.2024.e39871
Figure Legend Snippet: Changes in microvasculature lectin fluorescence pattern. A: the murine VA-VL brain area studied; B: micrograph shows the microvasculature profile in the ND + veh control group; C: ND + Stx2 treatment; D: HF + veh treatment; E: HF + Stx2 treatment; F: HC + veh treatment; G: HC + Sxt2 treatment; H: HF + HC + veh; I: HF + HC + Stx2; J: negative control by not adding Lycopersicum esculentum lectins; K: number of lectin-immunopositive particles; L: size of microvessels (μm2); M: area occupied by microvessels (%); arrow in B: a conserve microvessel; arrowheads in E: fragmented microvessels. Data were analyzed by one-way ANOVA and Bonferroni post hoc test, p = 0.0001, n = 5. Scale bar in J applies to all panels.
Techniques Used: Fluorescence, Control, Negative Control
Figure Legend Snippet: Changes in astrocyte GFAP expression. A: the murine internal capsule brain area studied; B: micrograph shows the astrocyte expression of GFAP in the ND + veh control group; C: ND + Stx2 treatment; D: HF + veh treatment; E: HF + Stx2 treatment; F: HC + veh treatment; G: HC + Stx2 treatment; H: HF + HC + veh treatment; I: HF + HC + Stx2 treatment; J: negative control by omitting primary antibody; K: quantification of GFAP expression levels in all treatments. Data were analyzed by one-way ANOVA and Bonferroni post hoc test, p = 0.0001, n = 5. Scale bar in J applies to all panels.
Techniques Used: Expressing, Control, Negative Control
Figure Legend Snippet: Changes in the neuron NeuN fluorescence patterns. A: the murine VA-VL brain area studied; B: micrograph shows NeuN localization in the ND + veh control group; C: ND + Stx2 treatment; D: HF + veh treatment; E: HF + Stx2 treatment; F: HC + veh treatment; G: HC + Stx2 treatment; H: HF + HC + veh treatment; I: HF + HC + Stx2 treatment; J: negative control by omitting primary antibody; K: quantification of nuclei with abnormal phenotypes in all treatments. Arrowhead in B: normal phenotype; arrow in I: abnormal phenotype. Data were analyzed by one-way ANOVA and Bonferroni post hoc test, p = 0.0001, n = 5. Scale bar in J applies to all panels.
Techniques Used: Fluorescence, Control, Negative Control
Figure Legend Snippet: Changes in Iba1 expression and number of Iba1-positive cells. A: the murine VA-VL brain area studied; B: micrograph shows the expression of Iba1 and the number of Iba1-positive cells in the ND + veh control group; C: ND + Stx2 treatment; D: HF + veh treatment; E: HF + Stx2 treatment; F: HC + veh treatment; G: HC + Stx2 treatment; H: HF + HC + veh treatment; I: HF + HC + Stx2 treatment; J: negative control by omitting primary antibody; K: quantification of Iba1 expression levels in all treatments. Data were analyzed by one-way ANOVA and Bonferroni post hoc test, p = 0.0001, n = 5. Scale bar in J applies to all panels.
Techniques Used: Expressing, Control, Negative Control
Figure Legend Snippet: Changes in MBP expression. A: the murine internal capsule brain area studied; B: micrograph shows the expression of MBP in the ND + veh control group; C: ND + Stx2 treatment; D: HF + veh treatment; E: HF + Stx2 treatment; F: HC + veh treatment; G: HC + Stx2 treatment; H: HF + HC + veh treatment; I: HF + HC + Stx2 treatment; J: negative control by omitting primary antibody; K: quantification of MBP expression levels in all treatments. Data were analyzed by one-way ANOVA and Bonferroni post hoc test, p < 0.005, n = 5. Scale bar in J applies to all panels.
Techniques Used: Expressing, Control, Negative Control
Figure Legend Snippet: Changes in mouse motor behavior. A: design of the test device; B: columns indicate the different treatments. Data were analyzed by one-way ANOVA and Bonferroni post hoc test, p = 0.0001, n = 10.
Techniques Used:
Figure Legend Snippet: Changes in mouse sensitivity. A: design of the test device; B: columns indicate the different treatments. Data were analyzed by one-way ANOVA and Bonferroni post hoc test, p = 0.0001, n = 10.
Techniques Used:
Related Articles
other:Article Title: Hydroxysafflor yellow A inhibits the hyperactivation of rat platelets by regulating the miR-9a-5p/SRC axis. Article Snippet: Pathological platelet activation plays a vital role in the prevalence of cardiovascular diseases.. Hydroxysafflor yellow A (HSYA) has been shown to have significant anti-platelet aggregation and anti-activation effects, but its mechanism of action is unclear.. Our study showed that HSYA inhibited the expression of platelet surface glycoproteins IIβ/III α (GPIIβ/III α) and thromboxane A2 (TXA2) during platelet activation and reduced platelet Ca2+ accumulation. Article Title: circNFXL1 Modulates the Kv2.1 Channel Function in Hypoxic Human Pulmonary Artery Smooth Muscle Cells via Sponging miR-29b-2-5p as a Competitive Endogenous RNA Article Snippet: The significant differences were examined using Article Title: circNFXL1 Modulates the Kv2.1 Channel Function in Hypoxic Human Pulmonary Artery Smooth Muscle Cells via Sponging miR-29b-2-5p as a Competitive Endogenous RNA Article Snippet: The significant differences were examined using |